Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: A dyadic-level analysis

Journal of Infectious Diseases

Volumn 210, Issue 6, 2014, Pages 846-852

  Burchell, Ann N ^a,b   Rodrigues, Allita ^b   Moravan, Veronika ^a   Tellier, Pierre Paul ^b   Hanley, James ^b   Coutlée, François ^b,c   Franco, Eduardo L ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Condoms; HPV vaccine; Human papillomavirus; Prevalence; Sex partners; Young adults

Indexed keywords

WART VIRUS VACCINE;

ADULT; CANADA; COHORT ANALYSIS; COITUS; CONCURRENT SEXUAL PARTNERSHIP; CONDOM; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; VACCINATION; WART VIRUS; YOUNG ADULT;

CONDOMS; HPV VACCINE; HUMAN PAPILLOMAVIRUS; PREVALENCE; SEX PARTNERS; YOUNG ADULTS;

ADOLESCENT; ADULT; CONDOMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; QUEBEC; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; YOUNG ADULT;

EID: 84907304655     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu200     Document Type: Conference Paper

References (47)

1. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813-9.
2. Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008; 17:2036-43.
3. Nielson CM, Flores R, Harris RB, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007; 16:1107-14.
4. Hernandez BY, Wilkens LR, Zhu X, et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis 2008; 197:787-94.
5. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Lyon, France: IARC, 2007. Report No.: Volume 90.
6. Giuliano AR, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 26(Suppl 10):K17-28.
7. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008; 26(Suppl 10):K1-16.
8. Morris M, Holmes K. Sexual partnership effects on STIs/HIV transmission. In: Holmes K, Sparling P, StammW, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill Medical, 2008:127-36.
9. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191:1796-807.
10. Muñoz N, Méndez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004; 190:2077-87.
11. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285:2995-3002.
12. Lu B, Wu Y, Nielson CM, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis 2009; 199:362-71.
13. Nielson CM, Harris RB, Dunne EF, et al. Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007; 196: 1137-45.
14. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-8.
15. UNAIDS Reference Group on Estimates, Modelling, and Projections: Working Group on Measuring Concurrent Sexual Partnerships. HIV: consensus indicators are needed for concurrency. The Lancet 2010; 375:621-2.
16. Kraut-Becher JR, Aral SO. Gap length: an important factor in sexually transmitted disease transmission. Sex Transm Dis 2003; 30:221-5.
17. Foxman B, Newman M, Percha B, Holmes KK, Aral SO. Measures of sexual partnerships: lengths, gaps, overlaps, and sexually transmitted infection. Sex Transm Dis 2006; 33:209-14.
18. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(Suppl 1):S1-15.
19. Burchell AN, Tellier P-P, Hanley J, Coutlée F, Franco EL. Human papillomavirus infections among couples in new sexual relationships. Epidemiol 2010; 21:31-7.
20. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283:81-6.
21. Sellors JW, Lorincz AT, Mahony JB, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000; 163:513-8.
22. Burchell AN, Tellier P-P, Hanley J, Coutlée F, Franco EL. Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner. Sex Transm Dis 2010; 37:34-40.
23. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004; 189:677-85.
24. Coutlée F, Rouleau D, Petignat P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 2006; 44:1998-2006.
25. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009; 10:321-2.
26. Barros AJD, Hirakata VN. Alternatives for logistic regression in crosssectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3:21.
27. Winer RL, Lee S-K, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-26.
28. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis 2002; 186:462-9.
29. Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196:1128-36.
30. Castellsagué X, Bosch FX, Muñoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346:1105-12.
31. Collins SI, Mazloomzadeh S, Winter H, et al. Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study. Int J Cancer 2005; 114:498-500.
32. Hernandez BY, Wilkens LR, Zhu X, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008; 14:888-94.
33. Widdice L, Ma Y, Jonte J, et al. Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis 2013; 207:1286-94.
34. Burchell AN, Coutlée F, Tellier P-P, Hanley J, Franco EL. Genital transmission of human papillomavirus in recently formed heterosexual couples. J Infect Dis 2011; 204:1723-9.
35. Giuliano AR, Lee J-H, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377:932-40.
36. Vaccarella S, Lazcano-Ponce E, Castro-Garduño JA, et al. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 2006; 119:1934-9.
37. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31:601-7.
38. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354:2645-54.
39. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29:725-35.
40. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006; 194:1044-57.
41. Burchell A, Tellier P, Coutlée F, Hanley J, Franco E. Evidence for the protective effect of condoms against male-to-female transmission. In: Poster P-622 presented at the 26th International Papillomavirus Conference, July 3-8, Montreal, Canada, 2010. http://www.hpvmedia.org/index.php?option=com- hpv&view=presentation&id=995. (Accessed 2011).
42. Bleeker MCG, Hogewoning CJA, Voorhorst FJ, et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003; 107:804-10.
43. Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30(Suppl 5):F123-38.
44. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999; 75:317-9.
45. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199:1263-9.
46. Heck JE, Berthiller J, Vaccarella S, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010; 39:166-81.
47. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis 1996; 174(Suppl 2):S201-13.